| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.1 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.1 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |